Pivotal OASIS 1 and 2 Phase III studies of investigational compound elinzanetant achieved a statistically significant reduction in frequency and severity of vasomotor symptoms
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer
EBITDA before special items falls 1.3 percent to € 4.41 billion
Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)
Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
The Unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms
The project funding will be done through a mix of internal accruals and debts.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
